These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 569367)

  • 1. Comparison of the myocardial protection offered by intermittent vs continuous potassium hypothermic cardioplegia during cardiopulmonary bypass.
    Pappis ML; DeRossi JF; Basuk R; Puma F; Adams PX; Cunningham JN
    Surg Forum; 1977; 28():285-8. PubMed ID: 569367
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of hypothermic potassium cardioplegia and superiority of continuous versus intermittent aortic cross-clamping.
    Roberts AJ; Abel RM; Alonso DR; Subramanian VA; Paul JS; Gay WA
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):44-58. PubMed ID: 7350388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of single-dose and multiple-dose crystalloid and blood potassium cardioplegia during prolonged hypothermic aortic occlusion.
    Takamoto S; Levine FH; LaRaia PJ; Adzick NS; Fallon JT; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):19-28. PubMed ID: 7350385
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of multidose cardioplegia and hypothermia in myocardial preservation during ischemic arrest.
    Engelman RM; Auvil J; O'Donoghue MJ; Levitsky S
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):555-63. PubMed ID: 642549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial protection with cold blood potassium cardioplegia during prolonged aortic cross-clamping. Laboratory evaluation.
    Catinella FP; Cunningham JN; Knopp EA; Srungaram RK; Nathan IM
    N Y State J Med; 1983 Apr; 83(5):721-6. PubMed ID: 6575278
    [No Abstract]   [Full Text] [Related]  

  • 6. Perfusion in cardioplegia: an experimental study.
    Addetia A; Callaghan JC
    Can J Surg; 1980 Mar; 23(2):146-50. PubMed ID: 7363175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection with cold, ischemic, potassium-induced cardioplegia.
    Roe BB; Hutchinson JC; Fishman NH; Ullyot DJ; Smith DL
    J Thorac Cardiovasc Surg; 1977 Mar; 73(3):366-74. PubMed ID: 839826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical importance of ensuring cardioplegic delivery with coronary stenoses.
    Becker H; Vinten-Johansen J; Buckberg GD; Follette DM; Robertson JM
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):507-15. PubMed ID: 7206757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of augmented myocardial blood flow on postischemic reperfusion injury.
    Coughlin TR; Levitsky S; O'Donoghue M; Feinberg H
    Surg Forum; 1979; 30():262-4. PubMed ID: 538616
    [No Abstract]   [Full Text] [Related]  

  • 10. Con: intermittent hypothermic cardioplegia is preferable to warm continuous cardioplegia for myocardial protection during cardiopulmonary bypass.
    Lell WA
    J Cardiothorac Anesth; 1990 Apr; 4(2):282-6. PubMed ID: 2131876
    [No Abstract]   [Full Text] [Related]  

  • 11. Pro: warm continuous cardioplegia is preferable to intermittent hypothermic cardioplegia for myocardial protection during cardiopulmonary bypass.
    Lichtenstein SV; Salerno TA; Slutsky AS
    J Cardiothorac Anesth; 1990 Apr; 4(2):279-81. PubMed ID: 2131875
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of multidose potassium-induced cardioplegia during prolonged aortic cross-clamping: comparison of continuous and intermittent clamping techniques.
    Roberts AJ; Abel RM; Subramanian VA; Paul J; Alonso DA; Gay WA
    Surg Forum; 1978; 29():279-81. PubMed ID: 401163
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous addition of adenosine with a micropump system improves warm whole blood cardioplegia.
    Agnihotri AK; Recanati MA; White JK; Titus J; Fischer JI; Schon J; Torchiana DF
    Heart Surg Forum; 2003; 6(4):264-72. PubMed ID: 12928212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog.
    Rosenfeldt FL; Hearse DJ; Canković-Darracott S; Braimbridge MV
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):29-38. PubMed ID: 7350386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioplegia and myocardial preservation during cardiopulmonary bypass.
    Engelman RM; Levitsky S; O'Donoghue MJ; Auvil J
    Circulation; 1978 Sep; 58(3 Pt 2):I107-13. PubMed ID: 14740689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion of inflow-limited myocardium following hypothermic potassium-induced cardioplegia.
    Chitwood WR; Hill RC; Wechsler AS
    J Thorac Cardiovasc Surg; 1984 Jul; 88(1):49-56. PubMed ID: 6738102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidose hypothermic potassium cardioplegia: clinical study of relationship between continuous aortic cross-clamp time and LV performance.
    Roberts AJ; Spies SM; Lichtenthal PR; Moran JM; Sanders JH; Michaelis LL
    Surg Forum; 1979; 30():255-7. PubMed ID: 317178
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial preservation: hypothermia vs beta adrenergic blockade.
    Kakos GS; Karayannacos PE; Baba N; Williams TE; Kilman JW; Vasko JS
    Surg Forum; 1975; 26():269-70. PubMed ID: 1216133
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional myocardial blood flow after hypothermic arrest and cardioplegia.
    Mittmann U; Baća I; Fey K; Saggau WW; Stadler R; Stieglitz HG; Storch H
    Thorac Cardiovasc Surg; 1979 Apr; 27(2):98-103. PubMed ID: 451986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypothermic K-cardioplegia and ATP-Mg solution on myocardial ATP content and function.
    Brown PR; Mulder DS; Chiu RC
    Surg Forum; 1979; 30():248-50. PubMed ID: 538611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.